Press Releases

Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.

Astrea Bioseparations Introduces Nereus LentiHERO, a Fit-for-purpose Solution for Lentiviral Vector Purification

Friday, September 30, 2022

Astrea Bioseparations a leading provider of novel purification and separation tools supporting the development of nextgeneration therapeutics has announced today the commercial launch of its Nereus LentiHERO lentiviral vector LVV purification technol...

VBI Vaccines Announces Initiation of Phase 1 Study of Multivalent Coronavirus Vaccine Candidate, VBI-2901

Thursday, September 29, 2022

VBI Vaccines Inc a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease today announced the initiation of enrollment in the Phase clinical study of VBI a multivalent enveloped viruslike partic...

Spectrum Chemical Signs U.S. Distribution Agreement with DFE Pharma to Provide BioHale® Brand Products for Biopharmaceutical Manufacturing

Thursday, September 29, 2022

Spectrum Chemical Mfg Corp a leading global provider of specialty fine and cGMP chemicals as well as laboratory equipment and supplies has entered into a new US

New MicroCNX Connectors a First for Small-Volume Aseptic Processing True alternative to tube welding at small tubing sizes

Wednesday, September 28, 2022

A new ultracompact sterile connector provides biopharmaceutical and cell and gene therapy manufacturers a muchneeded alternative to tube welding for their smallvolume closed aseptic processes MicroCNX Series Connectors are the newest addition to the...

Quanticate partners with Cancer Research UK to launch DETERMINE Study

Wednesday, September 28, 2022

Quanticate a global datafocused clinical research organisation CRO has partnered with leading cancer research organisation Cancer Research UK to launch the DETERMINE study which will test a range of therapies specifically targeting key genetic change...

Harrow Announces U.S. FDA Approval of IHEEZO™ (Chloroprocaine Hydrochloride Ophthalmic Gel) 3% for Ocular Surface Anesthesia

Wednesday, September 28, 2022

Harrow an eyecare pharmaceutical company exclusively focused on the discovery development and commercialization of innovative ophthalmic therapies and Sintetica SA a growing pharmaceutical company focused on analgesics local anesthetics and sterile i...

Cybin Obtains Exclusive License to a Novel Catalog of Psychedelic-Based Compounds

Tuesday, September 27, 2022

Cybin Inc a biopharmaceutical company focused on progressing Psychedelics to Therapeutics is pleased to announce that through its whollyowned subsidiary Cybin IRL Limited it has entered into an agreement with Mindset Pharma Inc to acquire an exclusiv...

Seagen and Zai Lab Announce Regional Strategic Collaboration and License Agreement for TIVDAK® (tisotumab vedotin-tftv)

Tuesday, September 27, 2022

Seagen Inc a world leader and pioneer in antibodydrug conjugate ADC therapies and Zai Lab Limited a patientfocused innovative commercialstage global biopharmaceutical company today announced an exclusive collaboration and license agreement for the de...

Nuvera PURE Reports name 2022 “best-in-class” pharmaceutical companies in oncology, neurology and immunology

Monday, September 26, 2022

Nuvera Life Science Consulting part of Ashfield Engage is pleased to announce its second annual awards for the three pharmaceutical companies designated as bestinclass by physicians and support staff surveyed for the companies PURE Reports AbbVie in...

BD, CerTest Biotec Announce US Commercial Launch of Monkeypox Assay

Monday, September 26, 2022

BD Becton Dickinson and Company a leading global medical technology company and CerTest Biotec today announced their newly developed molecular polymerase chain reaction PCR assay for monkeypox virus is now commercially available globally including in...